Keto in a pill? Jim Mellon debuts anti-aging joint venture with the Buck dedicated to inducing ketosis
Jim Mellon’s crew at Juvenescence has found its latest venture idea in a popular diet making its rounds in biotech circles.
Once again teaming up with the Buck Institute for Research on Aging, Juvenescence has launched BHB Therapeutics to explore preventative medicines that have potential to protect against age-related disease by inducing a state of ketosis, where the body burns fat instead of carbs, spurring the production of anti-inflammatory ketone bodies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.